This is the first study to demonstrate that kallistatin protects against ALI induced by LPS through attenuation of oxidative stress and inactivation of NF-κB, thereby reducing inflammatory mediator production and down-regulating Fas-mediated apoptosis. The gene discussed is FAS; the disease is acute respiratory distress syndrome.